
News|Articles|January 22, 2025
New Strategies for a Better Glycosylation Profile
Author(s)SCIEX
Glycan analysis provides key information on critical quality attributes that could affect stability, safety and efficacy of a protein therapeutic. Specific needs for understanding the glycosylation profiles change throughout the drug development process, but the requirement for high-resolution glycan information remains the same and is essential to help ensure product quality.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
Agenus Closes $141 Million Immunotherapy Collaboration with Zydus Lifesciences
2
Beyond Transactional: Collaborative Partnerships for Rapid, Flexible Biologics Development
3
Novartis Calls for Global Governments to Address Global Trade Policy
4
EC’s High-Dose Aflibercept Approval Highlights Durable Anti-VEGF Retinal Therapy
5